Treatment with High Dose [¹¹¹In-DTPA-D-PHE¹]-Octreotide in Patients with Neuroendocrine Tumors: Evaluation of Therapeutic and Toxic Effects

By Janson Eva Tiensuu   Eriksson Barbro   Öberg Kjell   Skogseid Britt   Öhrvall Ulf   Nilsson Sten   Westlin Jan-Erik  

Acta Oncologica, Vol. 38, Iss. 3, 1999-05 ,pp. : 373-377

Informa Healthcare

Access to resources Recommend Favorite

The role of combined imaging in metastatic medullary thyroid carcinoma: ¹¹¹In-DTPA-octreotide and ¹³¹I/¹²³I-MIBG as predictors for radionuclide therapy

By Gao Zairong   Biersack Hans   Ezziddin Samer   Logvinski Timur   An Rui  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 11, 2004-11 ,pp. : 649-656

Springer Publishing Company

Access to resources Recommend Favorite

Somatostatin Receptor Imaging of Small Cell Lung Cancer (SCLC) by Means of 111 In-DTPA Octreotide Scintigraphy

By Bombardieri E.   Crippa F.   Cataldo I.   Chiti A.   Seregni E.   Soresi E.   Boffi R.   Invernizzi G.   Buraggi G.L.  

European Journal of Cancer, Vol. 31, Iss. 2, 1995-01 ,pp. : 184-188

Elsevier

Access to resources Recommend Favorite

Biodistribution and Pharmacokinetics of ¹¹¹In-DTPA-Labelled Pegylated Liposomes after Intraperitoneal Injection

By Syrigos Konstantinos N.   Vile Richard G.   Peters A. Michael   Harrington Kevin J.  

Acta Oncologica, Vol. 42, Iss. 2, 2003-01 ,pp. : 147-153

Informa Healthcare

Access to resources Recommend Favorite

Effect of oral ZnDTPA on late effects of injected plutonium in rat

By Volf V.   Luz A.   Schaffer E.   Muller W. A.   Rencova J.  

International Journal of Radiation Biology, Vol. 75, Iss. 8, 1999-08 ,pp. : 929-941

Informa Healthcare

Access to resources Recommend Favorite